Research in Ristimäki Lab focuses on the molecular background of gastrointestinal tumors, mainly colorectal cancer and appendix-originating pseudomyxoma peritonei. In addition to understanding the molecular aberrations behind gastrointestinal tumorigenesis, our ultimate goal is to identify novel diagnostic biomarkers and therapy targets. Besides gene and protein level changes, we also study changes concerning cellular glycosylation.
Ari Ristimäki Group
Find Out More
Our lab is part of the Applied Tumor Genomics Research Program at the Faculty of Medicine, University of Helsinki (UH). Contact information...
Pseudomyxoma Peritonei Pseudomyxoma peritonei (PMP) is a rare malignant disease (1-2 cases per million per year) that most often originates...